Elevated CA19-9 within the normal range suggests poorer prognosis in stage II CRC: A retrospective analysis of a large sample in a single center
Although within the normal range, elevated CA19-9 was associated with an inferior prognosis, chemotherapy decisions of different intensities can be adjusted based on nomograms. This work will contribute to standardizing the diagnosis and treatment of stage II CRC and provide clinicians with essential insights for chemotherapy decisions.
Authors
- Xinxiang Li (ORCID: https://orcid.org/0000-0002-5902-3659)
- Zilan Ye
- Junyong Weng (ORCID: https://orcid.org/0000-0003-1826-3952)
- Ruoxin Zhang (ORCID: https://orcid.org/0000-0002-8846-3557)
- Fan Chen (ORCID: https://orcid.org/0000-0002-5739-2776)
Institutions
- Fudan University Shanghai Cancer Center (CN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2024-12-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_338_24
- Citations
- 2
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.84